Dingdang Health Technology Group Ltd.(HK:9886)
HK$0.87-0.01 (-0.57%)
HK:9886
Dingdang Health Technology Group Ltd. financials statements
HK$0.87
At close:-0.01 (-0.57%)
Want to see HK:9886 full AI Analyst Report?
Dingdang Health Technology Group Ltd. (9886) Ratios
1 Followers
Dingdang Health Technology Group Ltd. Ratios
HK:9886's free cash flow for Q2 2026 was ¥78.63M. For the 2026 fiscal year, HK:9886's free cash flow was decreased by ¥-5.37M and operating cash flow was ¥84.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.28 | 2.65 | 2.60 | 2.61 | 3.07 |
| Quick Ratio | 1.55 | 1.96 | 1.93 | 1.98 | 2.48 |
| Cash Ratio | 0.49 | 1.46 | 1.30 | 1.54 | 2.57 |
| Solvency Ratio | 0.08 | -0.34 | -0.08 | -2.26 | -0.23 |
| Operating Cash Flow Ratio | 0.16 | -0.01 | -0.01 | -0.24 | -0.50 |
| Short-Term Operating Cash Flow Coverage | 33.24 | 0.00 | 0.00 | 0.00 | -1635.94 |
| Net Current Asset Value | ¥ 977.14M | ¥ 1.25B | ¥ 1.34B | ¥ 1.29B | ¥ -4.50B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.06 | 0.05 | 0.04 | 1.33 |
| Debt-to-Equity Ratio | 0.17 | 0.09 | 0.06 | 0.07 | -1.84 |
| Debt-to-Capital Ratio | 0.14 | 0.08 | 0.06 | 0.07 | 2.19 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 2.28 |
| Financial Leverage Ratio | 1.70 | 1.59 | 1.37 | 1.69 | -1.38 |
| Debt Service Coverage Ratio | 3.87 | -19.28 | -10.53 | -36.75 | -35.03 |
| Interest Coverage Ratio | -4.32 | -24.20 | -35.31 | -41.23 | -37.17 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.35 |
| Interest Debt Per Share | 0.23 | 0.12 | 0.11 | 0.13 | 3.60 |
| Net Debt to EBITDA | -2.00 | 6.59 | 14.26 | 4.74 | -4.74 |
| Profitability Margins | |||||
| Gross Profit Margin | 35.26% | 32.95% | 31.10% | 38.94% | 33.65% |
| EBIT Margin | -1.09% | -4.61% | -4.39% | -7.54% | -17.96% |
| EBITDA Margin | 1.79% | -3.46% | -1.51% | -6.49% | -16.68% |
| Operating Profit Margin | -1.09% | -4.61% | -5.73% | -7.54% | -17.96% |
| Pretax Profit Margin | -0.63% | -7.93% | -4.55% | -65.42% | -43.00% |
| Net Profit Margin | -1.00% | -8.06% | -4.65% | -65.45% | -42.90% |
| Continuous Operations Profit Margin | -1.07% | -8.14% | -4.75% | -65.66% | -43.47% |
| Net Income Per EBT | 159.58% | 101.72% | 102.07% | 100.04% | 99.76% |
| EBT Per EBIT | 57.47% | 172.01% | 79.51% | 867.64% | 239.44% |
| Return on Assets (ROA) | -1.73% | -14.30% | -7.37% | -76.53% | -43.79% |
| Return on Equity (ROE) | -2.95% | -22.68% | -10.07% | -129.64% | 60.41% |
| Return on Capital Employed (ROCE) | -2.82% | -11.95% | -12.93% | -11.94% | -23.06% |
| Return on Invested Capital (ROIC) | -2.71% | -11.60% | -12.60% | -13.08% | -27.22% |
| Return on Tangible Assets | -1.80% | -15.16% | -8.44% | -86.48% | -50.11% |
| Earnings Yield | -3.93% | -60.62% | -9.65% | -20.55% | -12.04% |
| Efficiency Ratios | |||||
| Receivables Turnover | 17.06 | 19.53 | 21.05 | 9.59 | 21.97 |
| Payables Turnover | 6.84 | 8.37 | 8.24 | 9.46 | 11.18 |
| Inventory Turnover | 4.61 | 5.48 | 5.46 | 5.51 | 7.36 |
| Fixed Asset Turnover | 14.41 | 22.68 | 25.04 | 17.74 | 14.08 |
| Asset Turnover | 1.72 | 1.77 | 1.58 | 1.17 | 1.02 |
| Working Capital Turnover Ratio | 3.81 | 3.30 | 3.22 | 2.80 | 3.64 |
| Cash Conversion Cycle | 47.16 | 41.67 | 39.83 | 65.75 | 33.53 |
| Days of Sales Outstanding | 21.39 | 18.69 | 17.34 | 38.05 | 16.61 |
| Days of Inventory Outstanding | 79.16 | 66.60 | 66.79 | 66.27 | 49.57 |
| Days of Payables Outstanding | 53.39 | 43.62 | 44.31 | 38.57 | 32.66 |
| Operating Cycle | 100.56 | 85.29 | 84.13 | 104.32 | 66.18 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.12 | -0.01 | -0.00 | -0.17 | -0.28 |
| Free Cash Flow Per Share | 0.09 | -0.03 | -0.02 | -0.20 | -0.30 |
| Dividend Paid and CapEx Coverage Ratio | 4.82 | -0.45 | -0.25 | -6.60 | -10.56 |
| Capital Expenditure Coverage Ratio | 4.82 | -0.45 | -0.25 | -6.60 | -10.56 |
| Operating Cash Flow Coverage Ratio | 0.55 | -0.07 | -0.04 | -1.41 | -0.08 |
| Operating Cash Flow to Sales Ratio | 0.03 | -0.00 | -0.00 | -0.05 | -0.10 |
| Free Cash Flow Yield | 9.82% | -5.87% | -1.10% | -1.92% | -3.11% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -25.49 | -1.65 | -10.37 | -4.87 | -8.31 |
| Price-to-Sales (P/S) Ratio | 0.26 | 0.13 | 0.48 | 3.18 | 3.56 |
| Price-to-Book (P/B) Ratio | 0.75 | 0.37 | 1.04 | 6.31 | -5.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 10.18 | -17.04 | -90.68 | -52.05 | -32.11 |
| Price-to-Operating Cash Flow Ratio | 8.07 | -54.71 | -447.05 | -59.95 | -35.15 |
| Price-to-Earnings Growth (PEG) Ratio | 0.29 | -0.03 | 0.11 | -0.04 | 0.12 |
| Enterprise Value Multiple | 12.30 | 2.75 | -17.66 | -44.35 | -26.10 |
| Enterprise Value | 1.07B | -444.29M | 1.30B | 12.46B | 16.02B |
| EV to EBITDA | 12.30 | 2.75 | -17.66 | -44.35 | -26.10 |
| EV to Sales | 0.22 | -0.10 | 0.27 | 2.88 | 4.35 |
| EV to Free Cash Flow | 8.76 | 12.19 | -50.18 | -47.03 | -39.23 |
| EV to Operating Cash Flow | 6.94 | 39.14 | -247.37 | -54.16 | -42.95 |
| Tangible Book Value Per Share | 1.20 | 1.16 | 1.23 | 1.52 | -2.70 |
| Shareholders’ Equity Per Share | 1.28 | 1.26 | 1.68 | 1.63 | -1.95 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.70 | -0.03 | -0.04 | -0.00 | -0.01 |
| Revenue Per Share | 3.76 | 3.53 | 3.63 | 3.23 | 2.74 |
| Net Income Per Share | -0.04 | -0.28 | -0.17 | -2.11 | -1.18 |
| Tax Burden | 1.60 | 1.02 | 1.02 | 1.00 | 1.00 |
| Interest Burden | 0.57 | 1.72 | 1.04 | 8.68 | 2.39 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 |
| SG&A to Revenue | 0.26 | 0.27 | 0.05 | 0.08 | 0.13 |
| Stock-Based Compensation to Revenue | 0.01 | 0.02 | 0.03 | 0.04 | 0.09 |
| Income Quality | -5.03 | 0.03 | 0.02 | 0.20 | 0.24 |
Currency in CNY

